Department of Physics, Faculty of Natural Sciences, The Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Biotechnology and Nanomedicine, SINTEF, Trondheim, Norway.
Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway; Department of Radiology and Nuclear Medicine, St. Olav's University Hospital, Trondheim, Norway.
J Control Release. 2018 Jun 10;279:292-305. doi: 10.1016/j.jconrel.2018.04.026. Epub 2018 Apr 21.
Preclinical research has demonstrated that nanoparticles and macromolecules can accumulate in solid tumors due to the enhanced permeability and retention effect. However, drug loaded nanoparticles often fail to show increased efficacy in clinical trials. A better understanding of how tumor heterogeneity affects nanoparticle accumulation could help elucidate this discrepancy and help in patient selection for nanomedicine therapy. Here we studied five human tumor models with varying morphology and evaluated the accumulation of 100 nm polystyrene nanoparticles. Each tumor model was characterized in vivo using micro-computed tomography, contrast-enhanced ultrasound and diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging. Ex vivo, the tumors were sectioned for both fluorescence microscopy and histology. Nanoparticle uptake and distribution in the tumors were generally heterogeneous. Density of functional blood vessels measured by fluorescence microscopy correlated significantly (p = 0.0056) with nanoparticle accumulation and interestingly, inflow of microbubbles measured with ultrasound also showed a moderate but significant (p = 0.041) correlation with nanoparticle accumulation indicating that both amount of vessels and vessel morphology and perfusion predict nanoparticle accumulation. This indicates that blood vessel characterization using contrast-enhanced ultrasound imaging or other methods could be valuable for patient stratification for treatment with nanomedicines.
临床前研究表明,由于增强的通透性和保留效应,纳米粒子和大分子可以在实体瘤中积累。然而,载药纳米粒子在临床试验中往往未能显示出更高的疗效。更好地了解肿瘤异质性如何影响纳米粒子的积累,可以帮助阐明这种差异,并有助于为纳米医学治疗选择患者。在这里,我们研究了五种具有不同形态的人肿瘤模型,并评估了 100nm 聚苯乙烯纳米粒子的积累。使用微计算机断层扫描、对比增强超声以及扩散加权和动态对比增强磁共振成像,在体内对每个肿瘤模型进行了特征描述。在体外用荧光显微镜和组织学对肿瘤进行了切片。肿瘤内纳米粒子的摄取和分布通常是不均匀的。荧光显微镜测量的功能性血管密度与纳米粒子的积累显著相关(p=0.0056),有趣的是,超声测量的微泡流入也与纳米粒子的积累呈中度但显著相关(p=0.041),表明血管的数量、血管形态和灌注都可以预测纳米粒子的积累。这表明,使用对比增强超声成像或其他方法对血管进行特征描述可能对纳米药物治疗的患者分层有价值。